News | Proton Therapy | August 30, 2017

Educational event conducted in partnership with IBA and OncoLink will help participants understand the applications and benefits of proton therapy and the considerations of opening and running a proton therapy center

Penn Medicine to Host Fourth Annual Proton Therapy Training Course

August 30, 2017 — IBA (Ion Beam Applications S.A.) and the Department of Radiation Oncology at Penn Medicine, in partnership with OncoLink, will present the Fourth Annual Course on Proton Therapy from Nov. 17-19, 2017, in Philadelphia.

This educational opportunity presents medical professionals and administrators interested in proton therapy with a three-day proton therapy immersion program at Penn Medicine. The fourth presentation of this course will focus on Inspiring Innovation to Transform Patient Care. 

The course offers in-depth insights to the practical application of proton therapy for administrators, clinicians and medical physicists from cancer centers considering establishing proton therapy.

James Metz, M.D., chair, Penn Radiation Oncology and executive director, OncoLink said, “We are excited to offer this course for the fourth year. As the interest in proton therapy grows both nationally and internationally, Penn’s Roberts Proton Therapy Center continues to be a leader in providing education and training to help develop the next wave of experts in the field. We have been pioneers, both in regards to the technology and in building staff expertise, and we are pleased to showcase our Center and share our experience with the world.”

Anders Navrsted Pedersen, clinical director of the radiotherapy program at Copenhagen University Hospital (Rigshospitalet) in Denmark, commented, "I attended the course in order to advise patients, refer patients, prepare comparison dose plans and prepare for proton therapy in my own center."

Sanford Katz, M.D., radiation oncologist at the Willis-Knighton Cancer Center in Shreveport, La., said, “I returned from the seminar with interesting new views which we now consider for our treatment planning and program. All the speakers were approachable and encouraged us to contact them in case of questions, which really gave the feeling that if you were to embark on this big journey, you become part of and are backed up by a community of like-minded peers.”

Target audiences for the course are radiation oncology physicians, physicists and administrators who are interested in learning about proton therapy. At the end of this educational activity, participants should be able to:

  • Understand the logistics of establishing a proton therapy center with clinical and research capabilities;
  • Describe the current clinical indications and applications for proton therapy;
  • Comprehend the various technical considerations in proton therapy planning;
  • Explain the regulatory aspects of proton therapy planning and delivery from the standpoints of quality assurance and compliance; and
  • Better perform their specific roles within the proton therapy center

For more information: www.protontherapycourse.cvent.com


Related Content

News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
Subscribe Now